Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Platysma Prominence
NCT03915067Phase 2Completed
- Sponsor
- Allergan
- Start
- Apr 2019
- Primary completion
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of onabotulinumtoxinA in platysma prominence, sponsored by Allergan. Started Apr 2019; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
platysma prominence
Beyond the preview
Go deeper on NCT03915067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03915067.